Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: First in Human Study of IMGN151 in Recurrent Gynaecological Cancers [Phase 1]
This update covers the first-in-human Phase 1 study of IMGN151 in recurrent gynecologic cancers, sponsored by AbbVie, with the trial status …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Onco-primary Care Networking to Support TEAM-based Care [NA]
Clinical trial update noting that the Duke University study on oncology-primary care networking to support TEAM-based care is currently ACTI…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
This is a prospective, multicenter, single-arm observational study evaluating outcomes of low-risk endometrial cancer with isolated tumor ce…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy [NA]
A Dana-Farber Cancer Institute trial is exploring whether structured exercise can prevent immobility in patients with ovarian or endometrial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
A non-interventional study (NIS) evaluating the effectiveness and safety of durvalumab and olaparib in patients with endometrial cancer (DUO…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
Clinical trial update for GYN-AIDE, an AI-driven education/navigation tool in gynecologic oncology, focusing on endometrial cancer; status n…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence [NA]
Clinical trial update for a study on social interventions to support individuals undergoing treatment for endometrial cancer and its recurre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial [NA]
This ClinicalTrials.gov entry describes a non-inferiority randomized trial comparing sentinel lymph node mapping to comprehensive lymphadene…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]
TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
A clinical trial update notes that Endoscopic Suture Gastroplasty (ESG) is being studied as a treatment approach for obese patients with End…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
A Phase II, two-arm trial evaluating everolimus and letrozole with or without ribociclib (Lee011) in patients with advanced or recurrent end…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPINE: Maintenance Letrozole/Abemaciclib [Phase 2]
Phase 2 trial update for ALPINE evaluating maintenance letrozole plus abemaciclib in endometrial cancer and recurrent endometrial cancer; st…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial is evaluating the combination of lenvatinib, pembrolizumab, and paclitaxel for recurrent endometrial, ovarian, fallopian …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer [Phase 1]
Phase 1 clinical trial evaluating frontline immunotherapy combined with radiation and chemotherapy in high-risk endometrial cancer is active…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
A recruiting clinical trial from University Hospital Tuebingen is studying immunotherapy-related CRP kinetics in metastatic gynecological ca…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Endometrial Cell Collection With the PadKit [NA]
This clinical trial update indicates that the Endometrial Cell Collection with the PadKit study (NCT06464107), sponsored by Hackensack Merid…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: 3D Printed Custom Applicators for HDR BT (DISCO) [NA]
This clinical trial update notes that recruitment is ongoing for a study using 3D-printed custom applicators for high-dose-rate brachytherap…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer [Phase 3]
Phase 3 clinical trial comparing trastuzumab deruxtecan to standard chemotherapy in HER2-expressing endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry
This clinical registry study from Tata Memorial Hospital examines how molecular, pathological, and clinical features may influence adjuvant …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer [EARLY_Phase 1]
An early-phase study evaluating short-course radiation therapy combined with chemotherapy in people with endometrial cancer is currently rec…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery [Phase 2]
Phase 2 clinical trial evaluating the combination of radiation therapy with dostarlimab (TSR-042) in patients with endometrial cancer after …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
This clinical trial update outlines a prospective cohort study evaluating minimal residual disease testing to detect early recurrence in end…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer
This clinical trial update examines how dose and storage conditions of indocyanine green affect the efficacy and cost of sentinel lymph node…